Compare Tenet Healthcare Corporation (THC) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Veritone Inc — how do they compare? Tenet Healthcare Corporation trades at $260 (market cap $20.92B), while Veritone Inc trades at $0.61 (market cap $70.27M). The key difference: Tenet Healthcare Corporation is far larger — about 297.7× Veritone Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Veritone Inc for 12 Days on average.
| THC | VERI | |
|---|---|---|
Market Cap | $20.92B | $70.27M |
Volume | 455,764 | 9,630,093 |
Sector | Health | Technology |
52-Week High | $280.77 | $8.39 |
52-Week Low | $161.37 | $0.59 |
Typical Hold Time | 15 Days | 12 Days |
Enterprise Value | $32.00B | $105.66M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Veritone (VERI) trades at $0.6913, down 7.38% over 24 hours, reflecting persistent bearish technical momentum. The company reported a net loss of $111.73 million in 2025, with a negative net income margin of -117.54%, though it maintains a gross profit margin of 66.2%. Recent developments include a $15 million equity offering announced October 2026 and new partnerships, such as with ATP Media, to drive future revenue streams. Cash flow remains challenging, with negative operating cash flow offset by financing activities.
The investment outlook is highly speculative. Analyst consensus suggests significant upside with a $3.75 price target, but substantial execution risks exist. High cash burn, ongoing losses, and a securities class action investigation pose threats to shareholder value. The stock's deep value proposition hinges on successful AI solution adoption and cost management improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
